Clinical Trials Logo

Clinical Trial Summary

An extension of the MINVI trial, the MINVI Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of term/near term infants who received UCM or ECC.


Clinical Trial Description

The MINVI Follow-up trial will examine the difference in early childhood neurodevelopmental impairment of subjects enrolled in the MINVI trial using standardized neurological and developmental assessments at 22-26 months corrected age. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03621943
Study type Interventional
Source Sharp HealthCare
Contact
Status Completed
Phase N/A
Start date January 7, 2019
Completion date September 26, 2023

See also
  Status Clinical Trial Phase
Completed NCT04697147 - Zika and Neurodevelopment Among Infants in Grenada N/A
Completed NCT04888377 - ASPIRIN: Neurodevelopmental Follow-up Trial
Active, not recruiting NCT05504863 - RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
Completed NCT03718520 - The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
Completed NCT04607109 - Long-term Neurodevelopmental Disorders of Prematurely Born Children and Parental Experience
Completed NCT04118738 - International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy
Recruiting NCT03476980 - Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping) N/A
Completed NCT04652063 - Osteopathic Manipulative Medicine to Reduce Developmental Delays N/A
Recruiting NCT05186155 - Analysis of Ocular and Neurodevelopmental Function for Retinopathy of Prematurity
Recruiting NCT05996211 - The Swiss Neurodevelopmental Outcome Registry for Children With CHD
Completed NCT05901623 - ASQ Scores of Transient Hypothyroxinemia of Prematurity
Enrolling by invitation NCT04529382 - Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia
Recruiting NCT04347590 - Continuous Glucose Monitoring and Cerebral Oxygenation in Preterm Infants N/A
Active, not recruiting NCT03782610 - Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes